| Name | Title | Contact Details |
|---|
NDI Medical is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Beachwood, OH. To find more information about NDI Medical, please visit www.ndimedical.com
Expresso fitness headquartered in Santa Clara, CA is the industry leader in gamified fitness for the commercial market. Over the past 15 years, Expresso has brought millions of riders adventure, challenges and community on their world class interactive connected bikes. The company is on a mission to bring people together through fitness with innovative, social, and immersive workouts. With over 100 million workouts where members ride in virtual worlds, push themselves with heart rate training, and HIIT workouts inspired by gaming, the company is well on its way to make that happen.
Med USA is a Sandy, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.
Evans Analytical Group (EAG) has been a global leader in surface analysis and materials characterization for over 29 years, delivering innovative analytical services and solutions with uncompromising scientific integrity.